Clexane and Darunavir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clexane (enoxaparin sodium) and Darunavir (darunavir). Common drug interactions include face oedema among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Clexane and Darunavir. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Darunavir?

Darunavir has active ingredients of darunavir. eHealthMe is studying from 6,483 Darunavir users. Check the latest studies of Darunavir.



On Aug, 05, 2026

34 people who take Clexane and Darunavir together, and have interactions are studied.

Clexane and Darunavir drug interactions.

What are the common drug interactions of Clexane and Darunavir, by gender? *:

female:

  1. Face oedema (swelling of face)
  2. Localised oedema (fluid retention in a particular part of the body)
  3. Skin exfoliation (removal of the oldest dead skin cells)
  4. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  5. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  6. Pancreatitis acute (sudden inflammation of pancreas)
  7. Erythema (redness of the skin)
  8. Limb injury

male:

  1. Abdominal pain upper
  2. Diarrhoea
  3. Haemoglobin decreased
  4. Post procedural haemorrhage (post procedural bleeding)
  5. Puncture site haemorrhage (puncture site bleeding)
  6. Rash pustular (redness with pustules)
  7. Blood pressure decreased
  8. Asthenia (weakness)
  9. Blood pressure immeasurable
  10. Electrolyte imbalance

What are the common drug interactions of Clexane and Darunavir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Factor viii inhibition (suppression of factor viii)

50-59:

  1. Abdominal pain upper
  2. Diarrhoea
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Pyrexia (fever)
  6. Vomiting
  7. Dyspnoea (difficult or laboured respiration)
  8. Haemoglobin decreased
  9. Post procedural haemorrhage (post procedural bleeding)
  10. Puncture site haemorrhage (puncture site bleeding)

60+:

  1. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  2. Anaemia macrocytic (a macrocytic class of anaemia)
  3. Erythema (redness of the skin)
  4. Rash pustular (redness with pustules)
  5. Pancreatitis acute (sudden inflammation of pancreas)
  6. Asthenia (weakness)
  7. Electrolyte imbalance
  8. Hypertension (high blood pressure)
  9. Secondary adrenocortical insufficiency (inadequate secretion of acth by the pituitary gland)
  10. Thrombocytopenia (decrease of platelets in blood)

What are the existing conditions these people have? *

  1. High Blood Pressure: 13 people, 38.24%
  2. Thrombosis (formation of a blood clot inside a blood vessel): 8 people, 23.53%
  3. Stress And Anxiety: 8 people, 23.53%
  4. Pain: 8 people, 23.53%
  5. Pulmonary Embolism (blockage of the main artery of the lung): 6 people, 17.65%
  6. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 14.71%
  7. Diabetes: 5 people, 14.71%
  8. Agitation (state of anxiety or nervous excitement): 5 people, 14.71%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 11.76%
  10. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 8.82%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and Darunavir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clexane and Darunavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clexane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Darunavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clexane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Darunavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium and darunavir (the active ingredients of Clexane and Darunavir, respectively), and Clexane and Darunavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: